Stock DNA
Pharmaceuticals & Biotechnology
VND Million (Small Cap)
0
NA
0.00%
-0.30
35.58%
0.00
Revenue and Profits:
Net Sales:
162,124 Million
(Quarterly Results - Dec 2025)
Net Profit:
17,862 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.27%
0%
24.27%
6 Months
6.67%
0%
6.67%
1 Year
61.84%
0%
61.84%
2 Years
104.95%
0%
104.95%
3 Years
114.63%
0%
114.63%
4 Years
116.28%
0%
116.28%
5 Years
166.67%
0%
166.67%
Pharmedic Pharmaceutical Medicinal JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.64%
EBIT Growth (5y)
2.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
1.53
Tax Ratio
20.12%
Dividend Payout Ratio
273.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
79.55%
ROE (avg)
21.70%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.77
EV to EBITDA
-0.70
EV to Capital Employed
-0.42
EV to Sales
-0.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
33.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
162,124.20
126,519.10
28.14%
Operating Profit (PBDIT) excl Other Income
21,426.10
26,411.70
-18.88%
Interest
0.00
259.70
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17,862.10
19,380.60
-7.84%
Operating Profit Margin (Excl OI)
132.20%
186.30%
-5.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 28.14% vs -4.34% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -7.84% vs -13.34% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
546,566.50
498,185.00
9.71%
Operating Profit (PBDIT) excl Other Income
109,908.30
101,916.30
7.84%
Interest
302.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
82,304.90
58,497.20
40.70%
Operating Profit Margin (Excl OI)
179.10%
181.60%
-0.25%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 9.71% vs 2.68% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 40.70% vs -4.11% in Dec 2024
About Pharmedic Pharmaceutical Medicinal JSC 
Pharmedic Pharmaceutical Medicinal JSC
Pharmaceuticals & Biotechnology
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
Company Coordinates 
Company Details
367 Nguyen Trai, Phuong Nguyen Cu Trinh, Quan 1 HO CHI MINH None : None
Registrar Details






